期刊文献+

北京市回民医院维持性血液透析患者矿物质和骨代谢指标达标现状分析 被引量:5

下载PDF
导出
摘要 目的:调查我院维持性血液透析(MHD)患者矿物质和骨代谢水平,并探讨控制方法。方法:横断面调查研究我院血透中心61例MHD患者矿物质和骨代谢情况,以全段甲状旁腺激素(PTH)水平分组比较,分析高PTH的危险因素,并对高磷与各指标之间行相关性分析。结果 :61例MHD患者血磷达标率40.98%;校正血钙达标率59.02%;钙磷乘积达标率62.9%;血PTH达标率21.31%。PTH水平分组分析显示高磷、长透析龄与高PTH水平相关,2组间差异有统计学意义(P<0.05);Logistic回归分析透析龄、血磷与PTH水平呈显著正相关(P<0.05)。结论 :我院MHD患者矿物质和骨代谢水平达标率低。长透析龄、高血磷在继发性甲状旁腺功能亢进的发生过程中起促进作用。
出处 《中日友好医院学报》 2015年第3期182-183,共2页 Journal of China-Japan Friendship Hospital
基金 西城区可发展科研项目资助(SD2013-12)
  • 相关文献

参考文献7

  • 1张凌.慢性肾脏病钙磷代谢紊乱及骨病的处理[J].中国实用内科杂志,2010,30(2):113-115. 被引量:40
  • 2Kidney Disease:Improving Global Outcomes (KDIGO) CKD- MBO work Group.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J]. Kidney Znt,2009,76(Suppl 113) : 1-130.
  • 3McCarley PB,Arjomand M.Mineral and bone disorders in patients on dialysis:physiology and clinical consequences[J]. Nephrol Nurs J,2008,35(1);59-64.
  • 4Dialysis Outcomes and Practice Patterns Study.2010DOPPS annual report [EB/OL].http//www.dopps.org/annualreporffindex. html.
  • 5李铎,宋韩明,李文歌,姚力,张国锐,陈少轩,张凌.难治性继发性甲状旁腺功能亢进的相关因素分析[J].肾脏病与透析肾移植杂志,2012,21(2):115-119. 被引量:38
  • 6Sullivan C,Sayre SS,Leon JB,et al.Effect of food additives on hyperphosphatemia among patients with end-stage renal disease : a randomized controlled trial[J].JAMA, 2009,301 (6) : 629-635.
  • 7Zitt E,Fouque DJ,Acobson duction in dialysis patients ondary hyperparathyroidism SH,et al.Serum phosphorus re- treated with cinacalcet for sec- results mainly from parathyroid hormone reduction[J].Clin Kidney J,2013,6(3) :287-294.

二级参考文献23

  • 1<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 2陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:64
  • 3Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD- Related metabolic complications [J]. J Am Soc Nephrol, 2009 ;20 : 164 - 171.
  • 4Fraser WD. Hyperparathyroidism [ J ]. Lancet, 2009,347 : 145 - 157.
  • 5Goodman WG, Goldin J, Kuizon BD, et al. Coroary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [ J ]. N Eng J Med ,2000 ,342 : 1478 - 1483.
  • 6Kidney Disease : Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guidelines the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[ J]. Kidney Int, 2009,76 (Suppl 113 ) : S1- S130.
  • 7Teresa A, Joao MF. Cardiovascular risk in dialysis patients:X-ray vision on vascular calfications [ J ]. Kidney Int, 2008,74 : 1505 - 1507.
  • 8Bryan K, Dennis LA, Stephen MS, et al. Suevival following parathyroidectomy among United States dialysis patients [ J ]. Kidney Int ,2004,65:2010.
  • 9Moorthi RN, Moe SM. CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis,2011,58 (6) : 1022 - 1036.
  • 10Basile C,Lomonte C,Vernaglione L,et al. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant,2006,21 (4) : 968 - 974.

共引文献74

同被引文献33

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部